Mission

Bioperfectus, for a healthier future!

Vision

Dedicated to become one of the world's most reliable and highest quality IVD suppliers.

Core Value

Quality, Efficiency, Fairness and Justice.

Our Founders & Board Members
Fang Yongsheng
President

Former Deputy Director of Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences.

Dr. Wang Guoqiang
General Manager

Obtained Doctor Degree from Shanghai Medical College of Fudan University.Innovative and Entrepreneurial Talent of the Ministry of Science and Technology.Innovative and Entrepreneurial Talent in Jiangsu Province.

Dr. Liu Zhonghua
Technical Director & Deputy General Manager

Graduated from Xi’an Jiaotong University From 2005-2010, Dr. Liu served at the Institute of Pathogenic Biology, Chinese Academy of Medical Science; From 2008-2009, he worked at the New York Blood Center and Aaron Diamond AIDS Research Center, The Rockefeller University.

To be continued. . .
July 2021

Bioperfectus Antigen Rapid Test Kit was added to EU Common List.

July 2021

Bioperfectus Antigen Rapid Test Kit passed PEI evaluation and self-test version was granted by BfArM, Germany.

April 2021

COVID-19 Coronavirus Real Time PCR Kit was granted by SAHPRA, South Africa.

October 2020

Bioperfectus Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit was granted by RZN, Russia.

August 2020

Bioperfectus Virial Nucleic Acid Extraction Kit, SSNP-2000B, SSNP-3000A and SSNP-9600A were granted with FDA Listed.

July 2020

Bioperfectus COVID-19 Coronavirus Real Time PCR Kit was granted with WHO-EUL.

June 2020

Bioperfectus COVID-19 Coronavirus Real Time PCR Kit granted with FDA-EUA.

June 2020

International Sales & Marketing Division established.

May 2020

Bioperfectus COVID-19 Coronavirus Real Time PCR Kit was granted with TGA, Australia.

May 2020

Cooperation with Sinopharm to assist Myanmar fighting against COVID-19 (Nucleic acid extraction solution).

March 2020

Bioperfectus COVID-19 Coronavirus Real Time PCR Kit was granted with CE.


January 2020

Bioperfectus launched total COVID-19 testing solution to fight the pandemic globally

May 2019

Public-listed in Shanghai Stock Exchange.

January 2018

Bioperfectus became the official vendor of infectious disease control reagent during Shanghai Cooperation Organization.

January 2017

Bioperfectus became the official vendor of infectious disease control reagent during Belt and Road Forum for International Cooperation.

February 2016

Bioperfectus became the official vendor of infectious disease control reagent during G20 Hangzhou Summit.

January 2015
Bioperfectus hand-foot-mouth disease products were supported by National Torch Program.
January 2014
During Ebola Virus outbreak in Africa, Bioperfectus Ebola real-time PCR kits were donated to Africa.
January 2013

Developed the first H7N9 real-time PCR kit in China.

January 2010

Bioperfectus was established in China Medical City, Taizhou.